Alcon Inc. (SWX: ALC)
Switzerland
· Delayed Price · Currency is CHF | Market Cap | 40.35B |
| Revenue (ttm) | 8.66B |
| Net Income (ttm) | 990.26M |
| Shares Out | 494.50M |
| EPS (ttm) | 1.99 |
| PE Ratio | 40.92 |
| Forward PE | 29.60 |
| Dividend | 0.24 (0.29%) |
| Ex-Dividend Date | May 14, 2024 |
| Volume | 96,390 |
| Open | 80.70 |
| Previous Close | 81.60 |
| Day's Range | 80.08 - 80.72 |
| 52-Week Range | 61.28 - 84.42 |
| Beta | 0.72 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 13, 2024 |
About Alcon
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company’s Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic mi... [Read more]
Financial Performance
In 2023, Givaudan's revenue was 6.92 billion, a decrease of -2.84% compared to the previous year's 7.12 billion. Earnings were 893.00 million, an increase of 4.32%.
Financial numbers in USDNews
Alcon Analysts Increase Their Forecasts After Q2 Results
Alcon Inc. (NYSE: ALC) reported mixed second-quarter results, after the closing bell on Tuesday. Alcon reported quarterly earnings of 74 cents per share which beat the analyst consensus estimate of 7...
Alcon Analysts Increase Their Forecasts After Q2 Results
Alcon Inc. ALC reported mixed second-quarter results, after the closing bell on Tuesday.
Alcon CEO: 'Very good' revenue and underlying demand in Q2
Alcon CEO David Endicott comments on the company's second-quarter results.
Alcon CEO says firm had 'very good' revenue and underlying demand in the second quarter
Alcon CEO David Endicott comments on the company's second-quarter results.
Alcon Q2 Earnings Meet Estimates, Revenues Increase Y/Y
Alcon, Inc. (NYSE: ALC) delivered core earnings per share of 74 cents in the second quarter of 2024, up 7.2% from the year-ago quarter's figure (up 15% at the constant exchange rate or CER). The figu...
Alcon Inc. (ALC) Q2 2024 Earnings Call Transcript
Alcon Inc. (NYSE:NYSE:ALC) Q2 2024 Earnings Conference Call August 21, 2024 8:00 AM ETCompany ParticipantsDan Cravens - Vice President, Investor...
Earnings Summary: Alcon posts mixed Q2 results, FY24 sales outlook above estimates
Learn about the latest financial trends and tips to help you make informed decisions about your money.
Alcon down after hours following quarterly revenue miss; maintains 2024 outlook
Alcon down 5% after Q2 results miss on top line but beat on non-GAAP EPS. Read more here.
Alcon Non-GAAP EPS of $0.74 beats by $0.01, revenue of $2.5B misses by $30M
Alcon Reports Second-Quarter 2024 Results with Strong Growth in Implantables and Contact Lenses
GENEVA--(BUSINESS WIRE)--Alcon Reports Second-Quarter 2024 Results with Strong Growth in Implantables and Contact Lenses.
Alcon's Market Share Gains, New Launches Aid Growth
Alcon (NYSE: ALC) has been gaining from a strong pipeline and its focus on research and innovation. Market share gains also aid growth. The stock currently carries a Zacks Rank #2 (Buy). In Presbyopi...
Alcon Q2 2024 Earnings Preview
Alcon's Latest Equipment Breakthrough Technologies, Unity VCS and Unity CS, Receive U.S. FDA 510(k) Clearance
GENEVA--(BUSINESS WIRE)--Alcon's Latest Equipment Breakthrough Technologies, Unity VCS and Unity CS, Receive U.S. FDA 510(k) Clearance.
Alcon Reports Strong First-Quarter 2024 Results Driven by Robust Sales in Contact Lenses and Ocular Health
GENEVA--(BUSINESS WIRE)--Alcon Reports Strong First-Quarter 2024 Results Driven by Robust Sales in Contact Lenses and Ocular Health.
Alcon Announces Results of 2024 Annual General Meeting
GENEVA--(BUSINESS WIRE)--Alcon Announces Results of 2024 Annual General Meeting.
Alcon Publishes Agenda for 2024 Annual General Meeting
GENEVA--(BUSINESS WIRE)--Alcon Publishes Agenda for 2024 Annual General Meeting.
Vivity, the World's Leading EDOF IOL, Reaches One Million Milestone
TORONTO--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today proudly announces AcrySof® IQ Vivity® and Clareon® Vivity extended dep...
Alcon's Broad Portfolio Delivers Robust Sales and Earnings Growth in FY 2023
GENEVA--(BUSINESS WIRE)--Alcon's Broad Portfolio Delivers Robust Sales and Earnings Growth in FY 2023.
Alcon's stock falls as third-quarter sales miss estimates
Alcon Inc. shares ALC, +4.04% dropped more than 4% premarket on Wednesday after the eye care company on Tuesday reported third-quarter revenues below analysts' expectations.
Alcon Reports Third Quarter 2023 Results
GENEVA--(BUSINESS WIRE)--Alcon Reports Third Quarter 2023 Results.
Alcon Reports Second Quarter 2023 Results
GENEVA--(BUSINESS WIRE)--Alcon Reports Second Quarter 2023 Results.
Alcon CEO: Aging population and new technology driving eyecare business forward
David Endicott, CEO at Alcon, discusses first-quarter earnings, and shares his optimism for the business despite macroeconomic pressures.
Alcon Reports First Quarter 2023 Results
GENEVA--(BUSINESS WIRE)--Alcon Reports First Quarter 2023 Results.
Alcon's “The Lens” Interactive Compliance Training Experience Receives Coveted Anthem Award
GENEVA--(BUSINESS WIRE)--Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced that its interactive compliance training video experience, The Lens, has been...
Alcon Reports Fourth Quarter and Full Year 2022 Results
GENEVA--(BUSINESS WIRE)--Alcon Reports Fourth Quarter and Full Year 2022 Results